Furthermore, the results of GSEA analysis showed that CREB3L1 was obviously involved in modulating the immune response, immune relevant pathways and chemokine release in pan-cancer, further confirming the potential roles of CREB3L1 in the tumor immune microenvironment. The gene discussed is CREB3L1; the disease is cancer.